Review
doi: 10.1016/s0065-2776(08)60778-6.
Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells
Affiliations
- PMID: 1853786
- DOI: 10.1016/s0065-2776(08)60778-6
Item in Clipboard
Review
Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells
Adv Immunol.
1991.
No abstract available
Similar articles
-
Inhibition of early tumor growth requires J alpha 18-positive (natural killer T) cells.Cancer Res. 2003 Jun 15;63(12):3058-60. Cancer Res. 2003. PMID: 12810627
-
Strategies for immunotherapy of cancer.Adv Immunol. 2000;75:235-82. doi: 10.1016/s0065-2776(00)75006-1. Adv Immunol. 2000. PMID: 10879286 Review. No abstract available.
-
Tumor eradication by adoptive transfer of cytotoxic T lymphocytes.Adv Cancer Res. 1992;58:143-75. doi: 10.1016/s0065-230x(08)60294-8. Adv Cancer Res. 1992. PMID: 1532109 Review. No abstract available.
-
Exploiting dendritic cells and natural killer T cells in immunotherapy against malignancies.Trends Immunol. 2008 May;29(5):242-9. doi: 10.1016/j.it.2008.02.002. Epub 2008 Mar 26. Trends Immunol. 2008. PMID: 18372215 Review.
-
Cytotoxic T lymphocyte therapy of cancer and tumor escape mechanisms.Semin Cancer Biol. 1991 Oct;2(5):347-54. Semin Cancer Biol. 1991. PMID: 1773050 Review.
Cited by
-
Cancer patient T cells genetically targeted to prostate-specific membrane antigen specifically lyse prostate cancer cells and release cytokines in response to prostate-specific membrane antigen.Neoplasia. 1999 Jun;1(2):123-7. doi: 10.1038/sj.neo.7900018. Neoplasia. 1999. PMID: 10933046 Free PMC article.
-
Cell-mediated immune response to human papillomavirus infection.Clin Diagn Lab Immunol. 2001 Mar;8(2):209-20. doi: 10.1128/CDLI.8.2.209-220.2001. Clin Diagn Lab Immunol. 2001. PMID: 11238198 Free PMC article. Review. No abstract available.
-
A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4(+)FOXP3(+) regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix.Cell Mol Immunol. 2011 Jan;8(1):59-66. doi: 10.1038/cmi.2010.56. Epub 2010 Nov 22. Cell Mol Immunol. 2011. PMID: 21200385 Free PMC article.
-
Mutated mitogen-activated protein kinase: a tumor rejection antigen of mouse sarcoma.Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6375-9. doi: 10.1073/pnas.94.12.6375. Proc Natl Acad Sci U S A. 1997. PMID: 9177225 Free PMC article.
-
Therapeutic T cell engineering.Nature. 2017 May 24;545(7655):423-431. doi: 10.1038/nature22395. Nature. 2017. PMID: 28541315 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources